Plegridy 94 mcg/0,5 ml Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

plegridy 94 mcg/0,5 ml

biogen switzerland ag - peginterferonum beta-1a - 94 mcg/0,5 ml - peginterferonum beta-1a 94 µg l-arginini hydrochloridum, natrii acetas trihydricus, acido aceticum glaciale, polysorbatum 20, acqua iniectabilia q.s. per una soluzione invece di 0,5 ml. - multiple sklerose - biotechnologika

Plegridy 125 mcg/0,5 ml Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

plegridy 125 mcg/0,5 ml

biogen switzerland ag - peginterferonum beta-1a - 125 mcg/0,5 ml - peginterferonum beta-1a 125 µg l-arginini hydrochloridum, natrii acetas trihydricus, acido aceticum glaciale, polysorbatum 20, acqua iniectabilia q.s. per una soluzione invece di 0,5 ml. - multiple sklerose - biotechnologika

Plegridy Pen 63 mcg/0,5 ml Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

plegridy pen 63 mcg/0,5 ml

biogen switzerland ag - peginterferonum beta-1a - 63 mcg/0,5 ml - peginterferonum beta-1a 63 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika

Plegridy Pen 94 mcg/0,5 ml Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

plegridy pen 94 mcg/0,5 ml

biogen switzerland ag - peginterferonum beta-1a - 94 mcg/0,5 ml - peginterferonum beta-1a 94 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika

Plegridy Pen 125 mcg/0,5 ml Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

plegridy pen 125 mcg/0,5 ml

biogen switzerland ag - peginterferonum beta-1a - 125 mcg/0,5 ml - peginterferonum beta-1a 125 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika

Nerventra Union européenne - italien - EMA (European Medicines Agency)

nerventra

teva pharma gmbh - laquinimod - sclerosi multipla - il trattamento della sclerosi multipla.

Plegridy 125 mcg/0.5 ml Injektionslösung in einer Fertigspritze zur intramuskulären Anwendung Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

plegridy 125 mcg/0.5 ml injektionslösung in einer fertigspritze zur intramuskulären anwendung

biogen switzerland ag - peginterferonum beta-1a - injektionslösung in einer fertigspritze zur intramuskulären anwendung - peginterferonum beta-1a 125 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika